1-3 of 3
Ilan M. Kirsch, MD
Close
Sort by
Journal Articles

Activation of CRLF2/IL7RA Signaling in Normal Human Cord Blood Hematopoietic Progenitors Induces Philadelphia-like B-Cell Precursor Pre-Leukemia and Leukemia In Vivo

Ifat Geron, PhD, Angela Maria Savino, PhD, Noa Tal, MD PhD, John Brown, PhD, Virginia A Turati, DPhil, Yu Nee Lee, PhD, Chela James, PhD, Avigail Rein Gil, MD, Yehudit Birger, PhD, Inna Muler, Michal Hameiri, PhD, Victoria Marcu-Malina, PhD, Ute Fischer, PhD, Arndt Borkhardt, MD, Ilan M. Kirsch, MD, Arnon Nagler, MD, Tariq Enver, PhD, Shai Izraeli, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 566.
https://doi.org/10.1182/blood-2018-99-115913
Published: 2018
Journal Articles

Measurable Residual Disease (MRD) Testing in Multiple Myeloma Using an Improved Testing Technology: Population Impact

Marita Zimmermann, PhD MPH, Ilan M. Kirsch, MD, Josh Carlson, MPH, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4685.
https://doi.org/10.1182/blood.V130.Suppl_1.4685.4685
Published: 2017
Journal Articles

Residual Disease Monitoring By High Throughput Sequencing Provides Risk Stratification in Childhood B-ALL and Identifies a Novel Subset of Patients Having Poor Outcome

Brent L. Wood, MD PhD, David Wu, MD PhD, Ilan M. Kirsch, MD, Beryl Crossley, BS, David Williamson, Charles Gawad, MD, Michael J. Borowitz, MD PhD, Meenakshi Devidas, PhD, Kelly W. Maloney, MD, Eric Larsen, MD, Naomi Winick, MD, Elizabeth Raetz, MD, William L. Carroll, MD, Stephen P. Hunger, MD, Mignon L. Loh, MD, Harlan Robins, PhD
Journal: Blood
Blood (2016) 128 (22): 1086.
https://doi.org/10.1182/blood.V128.22.1086.1086
Published: 2016